Would you offer salvage radiation in a patient s/p radical prostatectomy with imaging showing local recurrence as well as oligometastatic disease in the pelvis?  

Would you treat the entire pelvis vs local recurrence? How would you approach the oligometastatic lesion? Would your treatment recommendation change if the patient did not have radiographic evidence of local recurrence in the prostate bed? Assume the patient is initiating combined androgen suppression with GNRH-inhibitor and novel oral androgen-signaling inhibitor.